P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.

Wu, Yucai; Peng, Yiji; Guan, Bao; He, Anbang; Yang, Kunlin; He, Shiming; Gong, Yanqing; Li, Xuesong; Zhou, Liqun

Wu, Yucai; Peng, Yiji; Guan, Bao; He, Anbang; Yang, Kunlin; He, Shiming; Gong, Yanqing; Li, Xuesong; Zhou, Liqun.

Afiliación

Wu Y; Department of Urology, Peking University First Hospital, Xicheng, Beijing 100034, P.R. China.
Peng Y; Institute of Urology, Peking University, Xicheng, Beijing 100034, P.R. China.
Guan B; National Urological Cancer Center, Peking University, Xicheng, Beijing 100034, P.R. China.
He A; Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Xicheng, Beijing 100034, P.R. China.
Yang K; Department of Urology, Peking University First Hospital, Xicheng, Beijing 100034, P.R. China.
He S; Institute of Urology, Peking University, Xicheng, Beijing 100034, P.R. China.
Gong Y; National Urological Cancer Center, Peking University, Xicheng, Beijing 100034, P.R. China.
Li X; Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Xicheng, Beijing 100034, P.R. China.
Zhou L; Department of Urology, Peking University First Hospital, Xicheng, Beijing 100034, P.R. China.

Oncol Lett ; 21(2): 95, 2021 Feb.

Article en En | MEDLINE | ID: mdl-33376528

Palabras clave

ER stress; beta polypeptide; bladder cancer; diagnostic; prognostic marker; prolyl 4-hydroxylase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2021 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google